Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Oncology Clinical Trials
Everolimus Safe and Effective for Advanced pNET: Final Results of RADIANT-3
MM-398 Plus 5-FU and LV Extend OS and PFS in mPAC
MPACT Trial: SPARC Not Predictive or Prognostic in Pancreatic Cancer
Active Maintenance Therapy Prolongs TFS and PFS in CRC
Impact of First-Line Therapy on Selection of Second-Line Therapy in FIRE-3 Trial
Outcomes Similar with BEV or CET Added to Induction CT for mCRC
Regorafenib Improves OS in Asian Patients with mCRC after Previous Failure with Standard Therapy
Improving Clinical Trials in the Era of Targeted Therapies
Does Aspirin's Ability to Improve CRC Prognosis Depend on PIK3CA Mutation Status?
New Analysis of CRYSTAL Results Supports Patient Selection According to
RAS
Mutation Status to Maximize Benefit from CET Therapy
Pages
Previous
Next
1
2
3
4
5
6
7
8
